Retapamulin as a Decolonizing Agent for MRSA
Clinical trial NCT03304873 · COMPLETED
Trial details
- NCT number
- NCT03304873
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-01
- Primary completion
- 2019-02-13
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.